• Policy
• Will Boryung succeed in tackling Sprycel’s patent
• by Lee, Tak-Sun Dec 30, 2021 05:51am

• Policy
• The MFDS plans to approve Daewoong's Fexuprazan
• by Lee, Tak-Sun Dec 30, 2021 05:51am

• Company
• Donepezil Patch, which is about to be released
• by Dec 30, 2021 05:51am

• Company
• Patents for representative DM drugs are expected to expire
• by Kim, Jin-Gu Dec 29, 2021 05:58am

• Company
• A reimbursed optn in hormone-sensitive prostate cancer?
• by Eo, Yun-Ho Dec 29, 2021 05:58am

• Policy
• Paxlovid is a new weapon added to our fight against COVID-19
• by Lee, Jeong-Hwan Dec 29, 2021 05:58am

• Policy
• Gov-National Assembly introduce oral treatment for COVID-19
• by Lee, Jeong-Hwan Dec 29, 2021 05:57am

• Company
• LegoChem transfers candidate technology to British company
• by Chon, Seung-Hyun Dec 29, 2021 05:57am

• Company
• SK Bioscience will complete major facilities in Songdo
• by Chon, Seung-Hyun Dec 28, 2021 05:51am

• Policy
• Entry of FDA-approved new Chinese blood cancer drug imminent
• by Lee, Tak-Sun Dec 28, 2021 05:51am